These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 15660442)

  • 41. Delay in the initiation of HAART, poorer virological response, and higher mortality among HIV-infected injecting drug users in Spain.
    Rodríguez-Arenas MA; Jarrín I; del Amo J; Iribarren JA; Moreno S; Viciana P; Peña A; Sirvent JL; Vidal F; Lacruz J; Gutierrez F; Oteo JA; Asencio R; Castilla J; Hoyos SP;
    AIDS Res Hum Retroviruses; 2006 Aug; 22(8):715-23. PubMed ID: 16910826
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association between renal disease and outcomes among HIV-infected women receiving or not receiving antiretroviral therapy.
    Szczech LA; Hoover DR; Feldman JG; Cohen MH; Gange SJ; Goozé L; Rubin NR; Young MA; Cai X; Shi Q; Gao W; Anastos K
    Clin Infect Dis; 2004 Oct; 39(8):1199-206. PubMed ID: 15486845
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A sequential Cox approach for estimating the causal effect of treatment in the presence of time-dependent confounding applied to data from the Swiss HIV Cohort Study.
    Gran JM; Røysland K; Wolbers M; Didelez V; Sterne JA; Ledergerber B; Furrer H; von Wyl V; Aalen OO
    Stat Med; 2010 Nov; 29(26):2757-68. PubMed ID: 20803557
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mortality among participants in the Multicenter AIDS Cohort Study and the Women's Interagency HIV Study.
    Hessol NA; Kalinowski A; Benning L; Mullen J; Young M; Palella F; Anastos K; Detels R; Cohen MH
    Clin Infect Dis; 2007 Jan; 44(2):287-94. PubMed ID: 17173233
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Short communication. Association of the CCR5delta32 mutation with clinical response and >5-year survival following initiation of first triple antiretroviral regimen.
    Brumme ZL; Henrick BM; Brumme CJ; Hogg RS; Montaner JS; Harrigan PR
    Antivir Ther; 2005; 10(7):849-53. PubMed ID: 16312181
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Progression to AIDS and death and response to HAART in men and women from a multicenter hospital-based cohort.
    Perez-Hoyos S; Rodríguez-Arenas MA; García de la Hera M; Iribarren JA; Moreno S; Viciana P; Peña A; Gómez Sirvent JL; Saumoy M; Lacruz J; Padilla S; Oteo JA; Asencio R; Del Amo J;
    J Womens Health (Larchmt); 2007 Sep; 16(7):1052-61. PubMed ID: 17903082
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical outcome of HIV-infected patients with sustained virologic response to antiretroviral therapy: long-term follow-up of a multicenter cohort.
    Gutierrez F; Padilla S; Masiá M; Iribarren JA; Moreno S; Viciana P; Muñoz L; Gómez Sirvent JL; Vidal F; López-Aldeguer J; Blanco JR; Leal M; Rodríguez-Arenas MA; Perez Hoyos S;
    PLoS One; 2006 Dec; 1(1):e89. PubMed ID: 17183720
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Survival of a large cohort of HIV-infected tuberculosis patients in the era of highly active antiretroviral treatment.
    Català L; Orcau A; García de Olalla P; Millet JP; Rodríguez-Mondragón A; Caylà JA;
    Int J Tuberc Lung Dis; 2011 Feb; 15(2):263-9, i. PubMed ID: 21219692
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.
    Clifford GM; Polesel J; Rickenbach M; Dal Maso L; Keiser O; Kofler A; Rapiti E; Levi F; Jundt G; Fisch T; Bordoni A; De Weck D; Franceschi S;
    J Natl Cancer Inst; 2005 Mar; 97(6):425-32. PubMed ID: 15770006
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Analyzing direct and indirect effects of treatment using dynamic path analysis applied to data from the Swiss HIV Cohort Study.
    Røysland K; Gran JM; Ledergerber B; von Wyl V; Young J; Aalen OO
    Stat Med; 2011 Oct; 30(24):2947-58. PubMed ID: 21800346
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Highly active antiretroviral therapy and survival in HIV-infected injection drug users.
    Wood E; Hogg RS; Lima VD; Kerr T; Yip B; Marshall BD; Montaner JS
    JAMA; 2008 Aug; 300(5):550-4. PubMed ID: 18677027
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cumulative HIV viremia during highly active antiretroviral therapy is a strong predictor of AIDS-related lymphoma.
    Zoufaly A; Stellbrink HJ; Heiden MA; Kollan C; Hoffmann C; van Lunzen J; Hamouda O;
    J Infect Dis; 2009 Jul; 200(1):79-87. PubMed ID: 19476437
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impact of highly active antiretroviral therapy on the morbidity and mortality in Spanish human immunodeficiency virus-infected children.
    Sánchez JM; Ramos Amador JT; Fernández de Miguel S; González Tomée MI; Rojo Conejo P; Ferrnado Vivas P; Clemente Vivas J; Ruiz Contreras J; Nogales Espert A
    Pediatr Infect Dis J; 2003 Oct; 22(10):863-7. PubMed ID: 14551485
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Structural Nested Cumulative Failure Time Models to Estimate the Effects of Interventions.
    Picciotto S; Hernán MA; Page JH; Young JG; Robins JM
    J Am Stat Assoc; 2012; 107(499):. PubMed ID: 24347749
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Adjusting for time-varying confounders in survival analysis using structural nested cumulative survival time models.
    Seaman S; Dukes O; Keogh R; Vansteelandt S
    Biometrics; 2020 Jun; 76(2):472-483. PubMed ID: 31562652
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Limitation of inverse probability-of-censoring weights in estimating survival in the presence of strong selection bias.
    Howe CJ; Cole SR; Chmiel JS; Muñoz A
    Am J Epidemiol; 2011 Mar; 173(5):569-77. PubMed ID: 21289029
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Causal proportional hazards models and time-constant exposure in randomized clinical trials.
    Loeys T; Goetghebeur E; Vandebosch A
    Lifetime Data Anal; 2005 Dec; 11(4):435-49. PubMed ID: 16328570
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Causal inference in survival analysis using pseudo-observations.
    Andersen PK; Syriopoulou E; Parner ET
    Stat Med; 2017 Jul; 36(17):2669-2681. PubMed ID: 28384840
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Instrumental variable estimation of the marginal structural Cox model for time-varying treatments.
    Cui Y; Michael H; Tanser F; Tchetgen Tchetgen E
    Biometrika; 2023 Mar; 110(1):101-118. PubMed ID: 36798841
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ensemble learning of inverse probability weights for marginal structural modeling in large observational datasets.
    Gruber S; Logan RW; Jarrín I; Monge S; Hernán MA
    Stat Med; 2015 Jan; 34(1):106-17. PubMed ID: 25316152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.